460 related articles for article (PubMed ID: 24652289)
1. Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.
Hançer NJ; Qiu W; Cherella C; Li Y; Copps KD; White MF
J Biol Chem; 2014 May; 289(18):12467-84. PubMed ID: 24652289
[TBL] [Abstract][Full Text] [Related]
2. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
Copps KD; Hançer NJ; Qiu W; White MF
J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin F2alpha represses IGF-I-stimulated IRS1/phosphatidylinositol-3-kinase/AKT signaling in the corpus luteum: role of ERK and P70 ribosomal S6 kinase.
Arvisais E; Hou X; Wyatt TA; Shirasuna K; Bollwein H; Miyamoto A; Hansen TR; Rueda BR; Davis JS
Mol Endocrinol; 2010 Mar; 24(3):632-43. PubMed ID: 20160123
[TBL] [Abstract][Full Text] [Related]
4. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of IRS1 at serine 307 in response to insulin in human adipocytes is not likely to be catalyzed by p70 ribosomal S6 kinase.
Rajan MR; Fagerholm S; Jönsson C; Kjølhede P; Turkina MV; Strålfors P
PLoS One; 2013; 8(4):e59725. PubMed ID: 23565163
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Irs1 at SER-522 inhibits insulin signaling.
Giraud J; Haas M; Feener EP; Copps KD; Dong X; Dunn SL; White MF
Mol Endocrinol; 2007 Sep; 21(9):2294-302. PubMed ID: 17579213
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cells.
Andreozzi F; D'Alessandris C; Federici M; Laratta E; Del Guerra S; Del Prato S; Marchetti P; Lauro R; Perticone F; Sesti G
Endocrinology; 2004 Jun; 145(6):2845-57. PubMed ID: 15001544
[TBL] [Abstract][Full Text] [Related]
8. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation.
Greene MW; Sakaue H; Wang L; Alessi DR; Roth RA
J Biol Chem; 2003 Mar; 278(10):8199-211. PubMed ID: 12510059
[TBL] [Abstract][Full Text] [Related]
9. Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907.
Fritsche L; Neukamm SS; Lehmann R; Kremmer E; Hennige AM; Hunder-Gugel A; Schenk M; Häring HU; Schleicher ED; Weigert C
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E824-36. PubMed ID: 21098738
[TBL] [Abstract][Full Text] [Related]
10. Evodiamine inhibits insulin-stimulated mTOR-S6K activation and IRS1 serine phosphorylation in adipocytes and improves glucose tolerance in obese/diabetic mice.
Wang T; Kusudo T; Takeuchi T; Yamashita Y; Kontani Y; Okamatsu Y; Saito M; Mori N; Yamashita H
PLoS One; 2013; 8(12):e83264. PubMed ID: 24391749
[TBL] [Abstract][Full Text] [Related]
11. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
[TBL] [Abstract][Full Text] [Related]
12. Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells.
Weigert C; Kron M; Kalbacher H; Pohl AK; Runge H; Häring HU; Schleicher E; Lehmann R
Mol Endocrinol; 2008 Dec; 22(12):2729-40. PubMed ID: 18927238
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 1 regulatory subunit 12A and catalytic subunit δ, new members in the phosphatidylinositide 3 kinase insulin-signaling pathway.
Geetha T; Langlais P; Caruso M; Yi Z
J Endocrinol; 2012 Sep; 214(3):437-43. PubMed ID: 22728334
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Soares HP; Ni Y; Kisfalvi K; Sinnett-Smith J; Rozengurt E
PLoS One; 2013; 8(2):e57289. PubMed ID: 23437362
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function.
Paz K; Liu YF; Shorer H; Hemi R; LeRoith D; Quan M; Kanety H; Seger R; Zick Y
J Biol Chem; 1999 Oct; 274(40):28816-22. PubMed ID: 10497255
[TBL] [Abstract][Full Text] [Related]
16. AMP-activated protein kinase inhibits IGF-I signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 S794 and tuberous sclerosis 2 S1345 phosphorylation.
Ning J; Clemmons DR
Mol Endocrinol; 2010 Jun; 24(6):1218-29. PubMed ID: 20363874
[TBL] [Abstract][Full Text] [Related]
17. Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.
Sanchez Canedo C; Demeulder B; Ginion A; Bayascas JR; Balligand JL; Alessi DR; Vanoverschelde JL; Beauloye C; Hue L; Bertrand L
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E761-9. PubMed ID: 20051528
[TBL] [Abstract][Full Text] [Related]
18. Carrageenan Inhibits Insulin Signaling through GRB10-mediated Decrease in Tyr(P)-IRS1 and through Inflammation-induced Increase in Ser(P)307-IRS1.
Bhattacharyya S; Feferman L; Tobacman JK
J Biol Chem; 2015 Apr; 290(17):10764-74. PubMed ID: 25784556
[TBL] [Abstract][Full Text] [Related]
19. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
20. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
